Frostbite drug reduces amputation risk.

FROSTBITE; TOES; AMPUTATION; RAYNAUD'S disease

The FDA has approved a drug called iloprost for the treatment of severe frostbite. In a clinical trial, patients who received iloprost alone did not require amputations, while 60% of patients who received a different drug did. Frostbite primarily affects individuals who spend a lot of time outside in the cold, such as construction workers and mountain climbers. Iloprost, which widens blood vessels and improves blood flow, has been used as a frostbite treatment in Europe and other parts of the world for years. The drug is administered intravenously and should ideally be given within 24 hours of the frostbite injury. This approval will benefit climbers and homeless individuals who are at risk of losing limbs due to frostbite. [Extracted from the article]

Copyright of Science News is the property of Society for Science & the Public and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)